1. From the Department of Haematology, Royal Free and University College Medical School, London, United Kingdom; Clinical Trials Unit, University Birmingham, Birmingham, United Kingdom; Department of Haematology, University of Wales, Cardiff, Wales, on behalf of the National Cancer Research Institute (NCRI) Adult Leukaemia Working Party, United Kingdom.